Anti-angiogenic drugs currently in Phase II clinical trials for gynecological cancer treatment

Author： Wei Xia-wei Zhang Zhi-rong Wei Yu-Quan

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.9, 2013-09, pp. : 1181-1192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment

By Engohang-Ndong Jean

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 12, 2012-12 ,pp. : 1789-1800

Informa Healthcare

Access to resources Recommend Favorite

Anti-Angiogenic Therapies for Children with Cancer

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 879-889

Bentham Science Publishers

Access to resources Recommend Favorite

Novel targets for VEGF-independent anti-angiogenic drugs

By Petrillo Marco Scambia Giovanni Ferrandina Gabriella

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 4, 2012-04 ,pp. : 451-472

Informa Healthcare

Access to resources Recommend Favorite

Are Anti-Angiogenic Drugs Useful in Neurodegenerative Disorders?

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 807-812

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: A ‘Hard Days Night'

Current Pharmaceutical Design, Vol. 20, Iss. 24, 2014-05 ,pp. : 3958-3972

Bentham Science Publishers

Access to resources Recommend Favorite